MA29038B1 - Derives de n-[(3 s)-pyrrolidine-3-yl]-benzamide servant d'inhibiteurs de reabsorption de monoamines - Google Patents
Derives de n-[(3 s)-pyrrolidine-3-yl]-benzamide servant d'inhibiteurs de reabsorption de monoaminesInfo
- Publication number
- MA29038B1 MA29038B1 MA29935A MA29935A MA29038B1 MA 29038 B1 MA29038 B1 MA 29038B1 MA 29935 A MA29935 A MA 29935A MA 29935 A MA29935 A MA 29935A MA 29038 B1 MA29038 B1 MA 29038B1
- Authority
- MA
- Morocco
- Prior art keywords
- reabsorption
- monoamines
- pyrrolidin
- inhibitors
- benzamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0425766.3A GB0425766D0 (en) | 2004-11-23 | 2004-11-23 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29038B1 true MA29038B1 (fr) | 2007-11-01 |
Family
ID=33548739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29935A MA29038B1 (fr) | 2004-11-23 | 2007-05-23 | Derives de n-[(3 s)-pyrrolidine-3-yl]-benzamide servant d'inhibiteurs de reabsorption de monoamines |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1817281A1 (nl) |
JP (1) | JP4233596B2 (nl) |
KR (1) | KR100886294B1 (nl) |
CN (1) | CN101065355A (nl) |
AP (1) | AP2007004003A0 (nl) |
AR (1) | AR052243A1 (nl) |
AU (1) | AU2005308534A1 (nl) |
BR (1) | BRPI0518486A2 (nl) |
CA (1) | CA2589258A1 (nl) |
CR (1) | CR9171A (nl) |
EA (1) | EA011217B1 (nl) |
GB (1) | GB0425766D0 (nl) |
GT (1) | GT200500337A (nl) |
IL (1) | IL183191A0 (nl) |
MA (1) | MA29038B1 (nl) |
MX (1) | MX2007006138A (nl) |
NL (2) | NL1030485C2 (nl) |
NO (1) | NO20072486L (nl) |
PA (1) | PA8653501A1 (nl) |
PE (1) | PE20061056A1 (nl) |
SV (1) | SV2006002311A (nl) |
TN (1) | TNSN07201A1 (nl) |
TW (1) | TWI300776B (nl) |
UY (1) | UY29224A1 (nl) |
WO (1) | WO2006056884A1 (nl) |
ZA (1) | ZA200703910B (nl) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH628885A5 (en) * | 1978-01-01 | 1982-03-31 | Anphar Sa | Piperidine derivative |
AP2005003467A0 (en) * | 2003-06-17 | 2006-12-31 | Pfizer | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors. |
GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
-
2004
- 2004-11-23 GB GBGB0425766.3A patent/GB0425766D0/en not_active Ceased
-
2005
- 2005-11-18 KR KR1020077014351A patent/KR100886294B1/ko not_active IP Right Cessation
- 2005-11-18 CN CNA2005800401025A patent/CN101065355A/zh active Pending
- 2005-11-18 JP JP2007542360A patent/JP4233596B2/ja not_active Expired - Fee Related
- 2005-11-18 WO PCT/IB2005/003643 patent/WO2006056884A1/en active Application Filing
- 2005-11-18 MX MX2007006138A patent/MX2007006138A/es active IP Right Grant
- 2005-11-18 AP AP2007004003A patent/AP2007004003A0/xx unknown
- 2005-11-18 BR BRPI0518486-0A patent/BRPI0518486A2/pt not_active IP Right Cessation
- 2005-11-18 CA CA002589258A patent/CA2589258A1/en not_active Abandoned
- 2005-11-18 AU AU2005308534A patent/AU2005308534A1/en not_active Abandoned
- 2005-11-18 EP EP05808510A patent/EP1817281A1/en not_active Withdrawn
- 2005-11-18 EA EA200700920A patent/EA011217B1/ru not_active IP Right Cessation
- 2005-11-21 PE PE2005001362A patent/PE20061056A1/es not_active Application Discontinuation
- 2005-11-21 AR ARP050104866A patent/AR052243A1/es not_active Application Discontinuation
- 2005-11-22 NL NL1030485A patent/NL1030485C2/nl not_active IP Right Cessation
- 2005-11-22 TW TW094140922A patent/TWI300776B/zh active
- 2005-11-22 GT GT200500337A patent/GT200500337A/es unknown
- 2005-11-22 UY UY29224A patent/UY29224A1/es not_active Application Discontinuation
- 2005-11-23 SV SV2005002311A patent/SV2006002311A/es unknown
- 2005-11-23 PA PA20058653501A patent/PA8653501A1/es unknown
-
2006
- 2006-10-27 NL NL1032760A patent/NL1032760C2/nl not_active IP Right Cessation
-
2007
- 2007-05-14 IL IL183191A patent/IL183191A0/en unknown
- 2007-05-15 ZA ZA200703910A patent/ZA200703910B/xx unknown
- 2007-05-15 NO NO20072486A patent/NO20072486L/no not_active Application Discontinuation
- 2007-05-22 TN TNP2007000201A patent/TNSN07201A1/fr unknown
- 2007-05-23 MA MA29935A patent/MA29038B1/fr unknown
- 2007-06-07 CR CR9171A patent/CR9171A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070086599A (ko) | 2007-08-27 |
EA011217B1 (ru) | 2009-02-27 |
NO20072486L (no) | 2007-06-20 |
AU2005308534A1 (en) | 2006-06-01 |
AP2007004003A0 (en) | 2007-06-30 |
GB0425766D0 (en) | 2004-12-22 |
KR100886294B1 (ko) | 2009-03-04 |
BRPI0518486A2 (pt) | 2008-11-18 |
CN101065355A (zh) | 2007-10-31 |
ZA200703910B (en) | 2008-09-25 |
TNSN07201A1 (fr) | 2008-11-21 |
GT200500337A (es) | 2006-06-13 |
PA8653501A1 (es) | 2006-06-02 |
CR9171A (es) | 2007-07-04 |
WO2006056884A1 (en) | 2006-06-01 |
JP2008520646A (ja) | 2008-06-19 |
UY29224A1 (es) | 2006-06-30 |
JP4233596B2 (ja) | 2009-03-04 |
EP1817281A1 (en) | 2007-08-15 |
TW200626543A (en) | 2006-08-01 |
EA200700920A1 (ru) | 2007-12-28 |
NL1032760A1 (nl) | 2006-12-13 |
NL1030485C2 (nl) | 2006-11-07 |
NL1030485A1 (nl) | 2006-05-24 |
NL1032760C2 (nl) | 2007-04-17 |
AR052243A1 (es) | 2007-03-07 |
CA2589258A1 (en) | 2006-06-01 |
IL183191A0 (en) | 2007-08-19 |
MX2007006138A (es) | 2007-07-19 |
TWI300776B (en) | 2008-09-11 |
SV2006002311A (es) | 2006-09-14 |
PE20061056A1 (es) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
EE200300459A (et) | Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena | |
IL182527A0 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
EP1613595A4 (en) | NOVEL COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN KINASE | |
ATE486597T1 (de) | 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie | |
MA28802B1 (fr) | Utilisations therapeutiques d'inhibiteurs de rtp801 | |
CY2017048I2 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
MA27230A1 (fr) | Derives d'aminoindazoles comme inhibiteurs de proteines-kinase | |
DK1756064T3 (da) | Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder | |
MA29119B1 (fr) | Derives de pyrrolidyle de composes heteroaromatiques servant d'inhibiteurs de phosphodiesterases | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
EP1626717A4 (en) | BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS | |
IL173440A0 (en) | Novel formulation of ropinirole | |
IL176922A0 (en) | Compositions and methods of use of a-type procyanidins | |
IL184268A0 (en) | N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid | |
ATE471326T1 (de) | Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i- epsilon | |
IL185035A0 (en) | Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine | |
EA200700400A1 (ru) | Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
WO2006047415A3 (en) | FACTOR Xa COMPOUNDS | |
MA28698B1 (fr) | Dicetopiperazines substituees utilisees comme antagonistes des oxytocines | |
IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
MXPA05009282A (es) | Derivados de anilina sustituidos. | |
PL1786759T3 (pl) | Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie | |
MA28811B1 (fr) | Nouvelles utilisations de derives d'imidazotriazinones substituees par 2-phenyle |